Synthesis and antiviral activity of N-adamantyl-2-amino(or 2-phenoxy)-acylamides

Dan Liu , Zi-chen Fan , Jia-mei Jiang , Jing Wei , Jian-chuang Xin

Chemical Research in Chinese Universities ›› 2013, Vol. 29 ›› Issue (4) : 706 -709.

PDF
Chemical Research in Chinese Universities ›› 2013, Vol. 29 ›› Issue (4) : 706 -709. DOI: 10.1007/s40242-013-2380-8
Article

Synthesis and antiviral activity of N-adamantyl-2-amino(or 2-phenoxy)-acylamides

Author information +
History +
PDF

Abstract

New N-adamantyl-2-amino-acylamides(3a–3f) and N-adamantyl-2-phenoxy-acetamides(6a–6d) were designed and synthesized by the modification of the amino group of amantadine 1 and the structures were confirmed by mass spectra(MS) and 1H NMR spectra. The antiviral potencies of the synthesized compounds were evaluated against the replication of influenza virus A/H3N2 subtype in Madin-Darby canine kidney(MDCK) cells. Among the amantadine derivatives, compound 3a had the strongest antiviral potency and showed activity similar to that of amantadine. Interestingly, the bulky and extended lipophilic moieties on the α-position of the carbonyl group resulted in decreases in potency.

Keywords

N-Adamantyl-2-amino(or 2-phenoxy)-acylamide / Antiviral activity / M2 proton channel

Cite this article

Download citation ▾
Dan Liu, Zi-chen Fan, Jia-mei Jiang, Jing Wei, Jian-chuang Xin. Synthesis and antiviral activity of N-adamantyl-2-amino(or 2-phenoxy)-acylamides. Chemical Research in Chinese Universities, 2013, 29(4): 706-709 DOI:10.1007/s40242-013-2380-8

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Peng S X. Progress in Medicinal Chemistry, 2011, Beijing: Chemical Industry Press 150.

[2]

Shigeta S, Mori S, Kodama E, Kodama J, Takahashi K, Yamase T. Antiviral Res., 2003, 58(3): 265.

[3]

Liu J, Mei W J, Li A X, Tan C P, Shi S, Ji L N. Chem. J. Chinese Universities, 2004, 25(1): 1.

[4]

Schnell J R, Chou J J. Nature, 2008, 451: 591.

[5]

Stouffer A L, Acharya R, Salom D, Levine A S, Costanzo L D, Soto C S, Tereshko V, Nanda V, Stayrook S, de Grado W F. Nature, 2008, 451: 596.

[6]

Lipatov A S, Govorkova E A, Webby R J, Ozaki H, Peiris M, Guan Y, Poon L, Webster R G. J. Virol., 2004, 78: 8951.

[7]

Kolocouris N, Foscolos G B, Kolocouris A, Marakos P, Pouli N, Fytas G, Ikeda S, de Clercq E. J. Med. Chem., 1994, 37: 2896.

[8]

Kolocouris A, Spearpoint P, Martin S R, Hay A, López-Querol M, Sureda F X, Padalko E, Neyts J, de Clercq E. Bioorg. Med. Chem. Lett., 2008, 18: 6156.

[9]

Stamatiou G, Kolocouris A, Kolocouris N, Fytas G, Foscolos G B, Neyts J, de Clercq E. Bioorg. Med. Chem. Lett., 2001, 11: 2137.

[10]

Tataridis D, Fytas G, Kolocouris A, Fytas C, Kolocouris N, Foscolos G B, Padalko E, Neyts J, de Clercq E. Bioorg. Med. Chem. Lett., 2007, 17: 692.

[11]

Zoidis G, Tsotinis A, Kolocouris N, Kelly J M, Prathalingam S R, Naesens L, de Clercq E. Org. Biomol. Chem., 2008, 6: 3177.

[12]

Zoidis G, Kolocouris N, Naesens L, de Clercq E. Bioorg. Med. Chem., 2009, 17: 1534.

[13]

Xiu Y J. Study on Syntheses of Natural Peptides Hirsutellide A and Tasiamide, 2004, Tianjin: Tianjin University.

[14]

Zhao Y, Yao J S, Dai G, Hu J Q. J. Shandong Inst. Light Ind., 2009, 23(2): 6.

[15]

Xie Y, Weng L L. West Chin. J. Pharm. Sci., 2005, 20(4): 310.

AI Summary AI Mindmap
PDF

105

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/